Prescribing pattern of bryophyllum preparations among a network of anthroposophic physicians

Forschende Komplementarmedizin

Volumn 19, Issue 6, 2012, Pages 293-301

  Simões Wüst, Ana Paula ^a   Jeschke, Elke ^b   Mennet, Mónica ^c   Schnelle, Martin ^c   Matthes, Harald ^b   Von Mandach, Ursula ^d  

^a Paracelsus Hospital   (Switzerland)

^b Havelhoehe Research Institute   (Germany)

^c WELEDA AG   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anthroposophic medicine; Bryophyllum; Complementary medicine; Kalanchoe; Mental and behavioral disorders

Indexed keywords

PLANT EXTRACT; UTERUS SPASMOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; CHILD; CLINICAL PRACTICE; CONNECTIVE TISSUE DISEASES; FEMALE; GERMANY; HUMAN; KALANCHOE; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; OBSTETRIC LABOR, PREMATURE; PHYTOTHERAPY; PREGNANCY; RETROSPECTIVE STUDY; SKIN DISEASES; SUBCUTANEOUS TISSUE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTHROPOSOPHY; CHILD; CONNECTIVE TISSUE DISEASES; FEMALE; GERMANY; HUMANS; KALANCHOE; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; OBSTETRIC LABOR, PREMATURE; PHYSICIAN'S PRACTICE PATTERNS; PHYTOTHERAPY; PLANT EXTRACTS; PREGNANCY; RETROSPECTIVE STUDIES; SKIN DISEASES; SUBCUTANEOUS TISSUE; TOCOLYTIC AGENTS; YOUNG ADULT;

EID: 84873341643     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000345841     Document Type: Article

References (41)

1. Kamboj A, Saluja A: Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and pharmacological profile: a review. Phcog Rev 2009;3:364-374.
2. Yadav NP, Dixit VK: Hepatoprotective activity of leaves of Kalanchoe pinnata Pers. J Ethnopharmacol 2003;86:197-202. (Pubitemid 36542877)
3. El Abdellaoui S, Destandau E, Toriboi A, et al.: Bioactive molecules in Kalanchoe pinnata leaves: extraction, purification, and identification. Anal Bioanal Chem 2010;398:1329-1338.
4. Lans CA: Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed 2006;2:45.
5. Nayak BS, Marshall JR, Isitor G: Wound healing potential of ethanolic extract of Kalanchoe pinnata Lam. leaf-a preliminary study. Indian J Exp Biol 2010;48:572-576.
6. Kamgang R, Mboumi RY, Fondjo AF, Tagne MA, N'dillé GP, Yonkeu JN: Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae). J Nat Med 2008;62:34-40. (Pubitemid 351176896)
7. Ojewole JA: Antinociceptive, anti-inflammatory and antidiabetic effects of Bryophyllum pinnatum (Crassulaceae) leaf aqueous extract. J Ethnopharmacol 2005;99:13-19. (Pubitemid 40569395)
8. Hamre HJ, Witt CM, Glockmann A, Tröger W, Willich SN, Kiene H: Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis. Drug Saf 2006;29:1173-1189. (Pubitemid 44904832)
9. Kienle G, Kiene H, Albonico H-U: Anthroposophic Medicine-Effectiveness, Utility, Costs, Safety. Stuttgart, Schattauer, 2006.
10. Hassauer W, Schreiber K, Von der Decken D: Ein neuer Weg in der tokolytischen Therapie. Erfahrungsheilkunde 1985;34:683-687.
11. Daub E: Vorzeitige Wehentätigkeit. Ihre Behandlung mit pflanzlichen Substanzen, eine klinische Studie. Stuttgart, Urachhaus, 1989.
12. Vilaghy I: Decreasing the rate of premature delivery with phytotherapy-results from general practice. (In German). Ther Umsch 2002;59:696-701.
13. Plangger N, Rist R, Zimmermann R, von Mandach U: Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. Eur J Obstet Gynecol Reprod Biol 2006;124: 168-172. (Pubitemid 43143073)
14. Gwehenberger B, Rist L, Huch R, von Mandach U: Effect of Bryophyllum pinnatum versus fenoterol on uterine contractility. Eur J Obstet Gynecol Reprod Biol 2004;113:164-171. (Pubitemid 38456770)
15. Wächter R, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Worel AM, Simões-Wüst AP, von Mandach U: Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine 2011;19:74-82.
16. Simões-Wüst AP, Grãos M, Duarte CB, Brenneisen R, Hamburger M, Mennet M, Ramos MH, Schnelle M, Wächter R, Worel AM, von Mandach U: Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells. Phytomedicine 2010;17:980-986.
17. Commission C: Monographien Kommission C. Bundesanzeiger 1992;121:272-277.
18. Gesellschaft Anthroposophischer Ärzte in Deutschland e.V. und Medizinische Sektion der Freien Hochschule für Geisteswissenschaft Dornach/Schweiz: Vademecum Anthroposophische Arzneimittel. Der Merkurstab 2008;61.
19. Jeschke E, Ostermann T, Tabali M, et al.: Diagnostic profiles and prescribing patterns in everyday anthroposophic medical practice-a prospective multi-centre study. Forsch Komplementmed 2009; 16:325-333.
20. Jeschke E, Ostermann T, Vollmar HC, et al.: Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians. BMC Neurol 2011;11:99.
21. Jeschke E, Ostermann T, Lüke C, Tabali M, Kröz M, Bockelbrink A, Witt CM, Willich SN, Matthes H: Remedies containing Asteraceae extracts: a prospective observational study of prescribing patterns and adverse drug reactions in German primary care. Drug Saf 2009;32:691-706.
22. Jeschke E, Ostermann T, Tabali M, Kröz M, Bockelbrink A, Witt CM, Willich SN, Matthes H: Anthroposophic medicine in pediatric primary care: a prospective, multicenter observational study on prescribing patterns. Altern Ther Health Med 2011; 17:18-28.
23. Jeschke E, Ostermann T, Tabali M, Vollmar HC, Kröz M, Bockelbrink A, Witt CM, Willich SN, Matthes H: Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study. BMC Geriatr 2010;10:48.
24. Jeschke E, Ostermann T, Vollmar HC, Kröz M, Bockelbrink A, Witt CM, Willich SN, Matthes H: Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study. BMC Fam Pract 2009;10:78.
25. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für Sozialmedizin und Prävention, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie, Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, Deutschen Gesellschaft für Sozialmedizin und Prävention: Good practice of secondary data analysis, first revision. (In German). Gesundheitswesen 2008; 70:54-60.
26. Chenot J-F, Heidenreich R: The role of ethics committes in primary care research projects. Z Allg Med 2004;80:271-291.
27. Mercier A, Auger-Aubin I, Lebeau J-P, Van Royen P, Peremans L: Understanding the prescription of antidepressants: a qualitative study among French GPs. BMC Fam Pract 2011;12:99.
28. Kjosavik SR, Hunskaar S, Aarsland D, Ruths S: Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway. Acta Psychiatr Scand 2011;123:459-465.
29. Gaind KN, Gupta RL: Flavonoid glycosides from Kalanchoe pinnata. Planta Med 1971;20:368-373.
30. Muzitano MF, Bergonzi MC, De Melo GO, Lage CL, Bilia AR, Vincieri FF, Rossi-Bergmann B, Costa SS: Influence of cultivation conditions, season of collection and extraction method on the content of antileishmanial flavonoids from Kalanchoe pinnata. J Ethnopharmacol 2011;133:132-137.
31. Muzitano MF, Tinoco LW, Guette C, Kaiser CR, Rossi-Bergmann B, Costa SS: The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry 2006;67:2071-2077. (Pubitemid 44301281)
32. Cao H, Xia J, Xu D, Lu B, Chen G: The separation and identification of the flavonoids from the leaves of Bryophyllum pinnatum. (In Chinese). Zhong Yao Cai 2005;28:988-990.
33. Supratman U, Fujita T, Akiyama K, Hayashi H: New insecticidal bufadienolide, bryophyllin C, from Kalanchoe pinnata. Biosci Biotechnol Biochem 2000;64:1310-1312.
34. Supratman U, Fujita T, Akiyama K, Hayashi H, Murakami A, Sakai H, Koshimizu K, Ohigashi H: Anti-tumor promoting activity of bufadienolides from Kalanchoe pinnata and K. daigremontiana tubiflora. Biosci Biotechnol Biochem 2001;65:947-949. (Pubitemid 33614186)
35. Gaind KN, Gupta RL: Phenolic components from the leaves of Kalanchoe pinnata. Planta Med 1973;23:149-153.
36. Nassis CZ, Haebisch EM, Giesbrecht AM: Antihistamine activity of Bryophyllum calycinum. Braz J Med Biol Res 1992;25:929-936.
37. Cruz EA, Da-Silva SA, Muzitano MF, Silva PM, Costa SS, Rossi-Bergmann B: Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. Int Immunopharmacol 2008;8:1616-1621.
38. Cruz EA, Reuter S, Martin H, Dehzad N, Muzitano MF, Costa SS, Rossi-Bergmann B, Buhl R, Stassen M, Taube C: Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomedicine 2012;19:115-121.
39. Pal S, Sen T, Chaudhuri AK: Neuropsychopharmacological profile of the methanolic fraction of Bryophyllum pinnatum leaf extract. J Pharm Pharmacol 1999;51:313-318. (Pubitemid 29192785)
40. Yemitan OK, Salahdeen HM: Neurosedative and muscle relaxant activities of aqueous extract of Bryophyllum pinnatum. Fitoterapia 2005;76:187-193. (Pubitemid 40326965)
41. Ojewole J: Antihypertensive properties of Bryophyllum pinnatum (Lamarck) Oken leaf extracts. Am J Hypertens 2002;15:34A-39A.